RxDoctor Payments Data

Laura McCarthy

Psychiatric/Mental Health · Linwood, NJNPI 1821579368

Payments from drug & device makers

$3,467in general payments, 2019–2025

Across 211 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$450
  • Axsome Therapeutics, Inc.$391
  • Otsuka America Pharmaceutical, Inc.$360
  • Neurocrine Biosciences, Inc.$286
  • Lundbeck LLC$200
  • plus $774 from 16 others

What the payments were for

  • Food & beverage$3,467100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,467 in reported general payments places this provider in the 85th percentile of 1,212 psychiatric/mental health providers in New Jersey.

See all psychiatric/mental health providers in New Jersey

Medicare billing

Part B allowed, 2024
$4,059
Medicare patients
20
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl62$4,303
Aripiprazole31$2,157
Quetiapine Fumarate68$1,897
Venlafaxine Hcl ErVenlafaxine Hcl71$1,460
Olanzapine48$1,402
Escitalopram Oxalate79$1,213
Mirtazapine52$1,134
Clonazepam69$977
Duloxetine Hcl36$874
Trazodone Hcl37$861
Alprazolam144$707
Methylphenidate ErMethylphenidate Hcl15$541
Paroxetine Hcl21$470
Lamotrigine22$454
Zolpidem Tartrate32$240

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Linwood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →